Free Trial

Gilead Sciences (GILD) SEC Filings & 10K Form

Gilead Sciences logo
$88.63 +0.88 (+1.00%)
(As of 11/20/2024 ET)

Recent Gilead Sciences SEC Filings

DateFilerForm TypeView
11/13/2024
4:13 PM
Gilead Sciences (Subject)
Form FWP
11/13/2024
8:02 AM
Gilead Sciences (Filer)
Form 424B5
11/06/2024
3:19 PM
Gilead Sciences (Subject)
Parsey Merdad (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
3:07 PM
Gilead Sciences (Subject)
Mercier Johanna (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
3:09 PM
Gilead Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
2:09 PM
Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
3:58 PM
Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
6:07 PM
Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:08 PM
Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:43 PM
Gilead Sciences (Subject)
Mercier Johanna (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2024
3:45 PM
Gilead Sciences (Subject)
Parsey Merdad (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2024
6:30 PM
Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
6:33 PM
Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
6:38 PM
Gilead Sciences (Issuer)
Patterson Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
6:41 PM
Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
6:20 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
6:23 PM
Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
2:23 PM
Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
1:23 PM
Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
4:17 PM
Gilead Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/26/2024
4:28 PM
Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
8:01 AM
Gilead Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2024
7:06 PM
Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
7:31 PM
ASSEMBLY BIOSCIENCES, INC. (Issuer)
Gilead Sciences (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
7:35 PM
ASSEMBLY BIOSCIENCES, INC. (Subject)
Gilead Sciences (Filed by)
Form SC 13D/A
06/11/2024
6:12 PM
Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:15 PM
Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:18 PM
Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:20 PM
Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:23 PM
Gilead Sciences (Issuer)
Patterson Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:25 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
4:57 PM
BARTON JACQUELINE K (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
4:16 PM
Gilead Sciences (Issuer)
MANWANI HARISH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
4:23 PM
Gilead Sciences (Issuer)
WELTERS ANTHONY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
4:26 PM
Gilead Sciences (Issuer)
Rodriguez Javier (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
4:30 PM
Gilead Sciences (Issuer)
LOVE TED W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
4:08 PM
Bluestone Jeffrey (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
8:29 PM
GALAPAGOS NV (Subject)
Gilead Sciences (Filed by)
Form SC 13D/A
04/19/2024
3:31 PM
Gilead Sciences (Reporting)
LEAP THERAPEUTICS, INC. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/19/2024
3:31 PM
Gilead Sciences (Filed by)
LEAP THERAPEUTICS, INC. (Subject)
Form SC 13G
04/05/2024
3:31 PM
Gilead Sciences (Filed by)
Xilio Therapeutics, Inc. (Subject)
Form SC 13G
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

04/03/2024
5:48 PM
Gilead Sciences (Reporting)
Xilio Therapeutics, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/03/2024
5:50 PM
Gilead Sciences (Reporting)
Xilio Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:38 PM
Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
4:19 PM
Gilead Sciences (Issuer)
Lofton Kevin E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:07 PM
Gilead Sciences (Filer)
Form DEF 14A
03/28/2024
3:07 PM
Gilead Sciences (Filer)
Form DEFA14A
03/22/2024
8:21 AM
Gilead Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2024
6:50 AM
CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
Form SC TO-T/A
03/20/2024
3:12 PM
CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
Form SC TO-T/A
03/15/2024
3:11 PM
CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
Form SC TO-T/A
03/12/2024
3:19 PM
Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
8:11 PM
Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
8:14 PM
Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:59 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
8:03 PM
Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:34 AM
CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
Form SC TO-T/A
02/29/2024
5:35 PM
Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:49 PM
Gilead Sciences (Subject)
Parsey Merdad (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2024
3:38 PM
Gilead Sciences (Subject)
Parsey Merdad (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/23/2024
5:09 AM
CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
Form SC TO-T
02/13/2024
4:48 PM
Gilead Sciences (Reporting)
Kyverna Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
7:37 AM
Gilead Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2024
7:39 AM
CymaBay Therapeutics, Inc. (Subject)
Gilead Sciences (Filed by)
Form SC TO-C
02/09/2024
5:21 PM
Capital World Investors (Filed by)
Gilead Sciences (Subject)
Form SC 13G/A
02/07/2024
4:35 PM
Gilead Sciences (Reporting)
Kyverna Therapeutics, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/06/2024
5:01 PM
Gilead Sciences (Issuer)
LOVE TED W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
3:20 PM
Gilead Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/02/2024
1:42 PM
Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
1:34 PM
Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
1:19 PM
Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
1:11 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
12:40 PM
Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:58 PM
Arcus Biosciences, Inc. (Subject)
Gilead Sciences (Filed by)
Form SC 13D/A
01/31/2024
4:00 PM
Arcus Biosciences, Inc. (Issuer)
Gilead Sciences (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
1:27 PM
BlackRock Inc. (Filed by)
Gilead Sciences (Subject)
Form SC 13G/A
01/17/2024
5:01 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
3:32 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:35 PM
Gilead Sciences (Subject)
Mercier Johanna (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/29/2023
3:36 PM
Gilead Sciences (Issuer)
Lofton Kevin E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
4:06 PM
Arcellx, Inc. (Subject)
Gilead Sciences (Filed by)
Form SC 13G/A
12/28/2023
4:09 PM
Arcellx, Inc. (Issuer)
Gilead Sciences (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/22/2023
3:07 PM
Gilead Sciences (Reporting)
HOOKIPA Pharma Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/11/2023
6:00 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
6:04 PM
Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
6:08 PM
Gilead Sciences (Issuer)
Patterson Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
6:10 PM
Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
6:15 PM
Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:GILD) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners